Clinical Report: The Translational Dilemma of AI in Hepatocellular Carcinoma
Overview
Expand on the specific challenges of validation and integration of AI in clinical settings.
Background
Hepatocellular carcinoma (HCC) is a leading cause of cancer-related mortality, necessitating improved diagnostic and treatment strategies. The integration of AI offers potential enhancements in HCC management by addressing limitations of conventional staging and assessment methods. However, the transition from theoretical models to practical applications is fraught with challenges, particularly regarding validation and clinical utility.
Data Highlights
Revise to indicate that the lack of numerical data limits the report's analytical depth.
Key Findings
AI has evolved from static pattern recognition to complex algorithms for spatial and imaging diagnostics in HCC.
Self-supervised Vision Foundation Models (VFMs) and AI-synergized spatial transcriptomics can theoretically decode intratumoral heterogeneity.
Complex AI models often lack validation in real-world multi-scanner cohorts, limiting their clinical applicability.
Traditional Cox models remain competitive for low-dimensional survival predictions compared to complex AI models.
There is a critical need for interpretable AI architectures to enhance clinical integration and utility.
Clinical Implications
Clinicians should remain cautious about the adoption of complex AI models in HCC management until further validation is achieved. Emphasizing interpretable AI systems may facilitate better integration into clinical workflows and improve patient outcomes.
Conclusion
Highlight the need for continuous research and validation in AI applications for HCC.
